Angioimmunoblastic T-cell lymphoma not achieve remission is a subtype of peripheral T-cell lymphoma characterized by the proliferation of abnormal T-cells. This condition is clinically significant as it often presents with systemic symptoms and can lead to severe complications. Accurate coding with ICD-10 Code C86.50 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this complex malignancy.
ICD-10 Code C86.50 represents Angioimmunoblastic T-cell lymphoma that has not achieved remission. This condition is a form of non-Hodgkin lymphoma characterized by immune dysregulation and lymphadenopathy. The code should be used in clinical documentation and billing when the patient has been diagnosed with this specific type of lymphoma and has not responded to treatment, indicating the need for ongoing management.
Angioimmunoblastic T-cell lymphoma not achieve remission is a hematological malignancy that arises from T-lymphocytes and is associated with immune system dysfunction. The condition can progress rapidly and requires immediate medical intervention to manage symptoms and prevent complications.
ICD-10 Code C86.50 is utilized in SOAP notes to document the patient's ongoing symptoms, assessment findings, and treatment plans. This code is crucial for both acute and chronic care settings, ensuring that the patient's condition is accurately represented in their medical records.
In SOAP notes, ICD-10 Code C86.50 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Angioimmunoblastic T-cell lymphoma not achieve remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Angioimmunoblastic T-cell lymphoma not achieve remission requires urgent medical attention and often necessitates hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C86.50 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 96415 | Chemotherapy administration, intravenous, infusion technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 85025 | Complete blood count with differential. |
Common Questions About Using ICD-10 Code C86.50 for Angioimmunoblastic T-cell lymphoma not achieve remission
What are the common symptoms of Angioimmunoblastic T-cell lymphoma?
Common symptoms include persistent lymphadenopathy, fever, night sweats, and weight loss. Patients may also experience skin rashes and fatigue due to immune dysregulation.
How is Angioimmunoblastic T-cell lymphoma treated?
Treatment typically involves chemotherapy and may include supportive care to manage symptoms. Close monitoring is essential to assess treatment response and adjust therapy as needed.
When should ICD-10 Code C86.50 be used?
This code should be used when documenting a diagnosis of Angioimmunoblastic T-cell lymphoma that has not achieved remission, indicating the need for ongoing treatment and management.
What is the importance of accurate coding for this condition?
Accurate coding is crucial for proper billing, ensuring appropriate reimbursement, and facilitating effective patient management and public health reporting.
Clinical Notes
SOAP notes
DAP notes
AI medical notes